Sci Pharmtech (TPE:4119) Additional Paid-In Capital : NT$2,234 Mil(As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Additional Paid-In Capital?

Sci Pharmtech's quarterly additional paid-in capital increased from Sep. 2023 (NT$1,377 Mil) to Dec. 2023 (NT$2,234 Mil) but then stayed the same from Dec. 2023 (NT$2,234 Mil) to Mar. 2024 (NT$2,234 Mil).

Sci Pharmtech's annual additional paid-in capital increased from Dec. 2021 (NT$1,348 Mil) to Dec. 2022 (NT$1,357 Mil) and increased from Dec. 2022 (NT$1,357 Mil) to Dec. 2023 (NT$2,234 Mil).

Sci Pharmtech Additional Paid-In Capital Historical Data

The historical data trend for Sci Pharmtech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Additional Paid-In Capital Chart

Sci Pharmtech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,348.34

1,357.13

2,233.59

Sci Pharmtech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,357.13	1,357.13	1,377.27	2,233.59	2,233.59

Sci Pharmtech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Sci Pharmtech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sci Pharmtech (TPE:4119) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856

Website

http://www.sci-pharmtech.com.tw

Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech (TPE:4119) Headlines

No Headlines